Mary E. Haas

Company: Regeneron Genetics Center

Job title: Co-Founder & Chief Medical Officer Head of Research & Development

Seminars:

2:00 PM Insights into Genetic Kidney Diseases from Whole Exome Sequencing at Scale 2:00 pm

Types of genetic analyses and their relevance for drug development Utility of whole exome sequencing to identify potential drug targets and provide complementary information on mutation prevalence and penetranceRead more

day: Conference Day 2